Cancer

GenomOncology Appoints Dr. Jack Lord to Board of Directors

CLEVELAND, Dec. 19, 2024 /PRNewswire/ -- GenomOncology is proud to announce the appointment of Dr. Jonathan "Jack" Lord, M.D., to its…

1 year ago

Medial EarlySign Reaches Milestone of 30 Validated Studies Published in Leading Journals and Scientific Poster Sessions

British Medical Journal Open Gastroenterology Publishes NHS Study Indicating ColonFlag™ Assists Detection of Colorectal Cancer TEL AVIV, Israel, Dec. 19, 2024…

1 year ago

GenBio AI Releases Phase 1 of World’s First Digital Organism to Transform Medical Research

PALO ALTO, Calif., Dec. 19, 2024 /PRNewswire/ -- Just as the transistor and microscope unlocked new waves of discovery, today,…

1 year ago

Caris Life Sciences Exceeds 1,000 Published Studies Milestone

IRVING, Texas, Dec. 19, 2024 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer,…

1 year ago

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications

Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially ADHD or other neuropsychiatric indicationsThe import was conducted…

1 year ago

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…

1 year ago

Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality

Autonomix Medical, Inc. Biotech/Med Device executive Continued efforts to build team and infrastructure required to support clinical and regulatory initiatives…

1 year ago

Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially…

1 year ago

Marker Therapeutics Announces $16.1 Million Private Placement

Strategic financing supports clinical advancement in Phase 1 APOLLO study investigating MT-601 in patients with lymphoma who relapsed after anti-CD19…

1 year ago